FI20105825A - Användning av blodgrupp status III - Google Patents

Användning av blodgrupp status III

Info

Publication number
FI20105825A
FI20105825A FI20105825A FI20105825A FI20105825A FI 20105825 A FI20105825 A FI 20105825A FI 20105825 A FI20105825 A FI 20105825A FI 20105825 A FI20105825 A FI 20105825A FI 20105825 A FI20105825 A FI 20105825A
Authority
FI
Finland
Prior art keywords
blood group
group status
status iii
iii
blood
Prior art date
Application number
FI20105825A
Other languages
English (en)
Finnish (fi)
Other versions
FI20105825A0 (sv
Inventor
Pirjo Wacklin
Jaana Maettoe
Harri Maekivuokko
Jukka Partanen
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Priority to FI20105825A priority Critical patent/FI20105825A/sv
Publication of FI20105825A0 publication Critical patent/FI20105825A0/sv
Priority to US13/812,799 priority patent/US20130195820A1/en
Priority to EP11808883.0A priority patent/EP2598155A2/en
Priority to PCT/FI2011/050674 priority patent/WO2012013861A2/en
Publication of FI20105825A publication Critical patent/FI20105825A/sv
Priority to US14/577,072 priority patent/US20150104423A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20105825A 2010-07-26 2010-07-26 Användning av blodgrupp status III FI20105825A (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI20105825A FI20105825A (sv) 2010-07-26 2010-07-26 Användning av blodgrupp status III
US13/812,799 US20130195820A1 (en) 2010-07-26 2011-07-26 Use of blood group status iii
EP11808883.0A EP2598155A2 (en) 2010-07-26 2011-07-26 Use of blood group status iii
PCT/FI2011/050674 WO2012013861A2 (en) 2010-07-26 2011-07-26 Use of blood group status iii
US14/577,072 US20150104423A1 (en) 2010-07-26 2014-12-19 Use of blood group status iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20105825A FI20105825A (sv) 2010-07-26 2010-07-26 Användning av blodgrupp status III

Publications (2)

Publication Number Publication Date
FI20105825A0 FI20105825A0 (sv) 2010-07-26
FI20105825A true FI20105825A (sv) 2012-01-27

Family

ID=42555518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105825A FI20105825A (sv) 2010-07-26 2010-07-26 Användning av blodgrupp status III

Country Status (2)

Country Link
US (2) US20130195820A1 (sv)
FI (1) FI20105825A (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2531589B1 (en) 2010-02-01 2017-04-05 MikrobEX Bacteriotherapy for Clostridium difficile colitis
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
PT3628161T (pt) 2012-11-23 2023-05-15 Seres Therapeutics Inc Composições bacterianas sinergísticas e métodos de produção e utilização das mesmas
US11185562B2 (en) 2013-02-04 2021-11-30 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
WO2014197562A1 (en) 2013-06-05 2014-12-11 Rebiotix, Inc. Microbiota restoration therapy (mrt), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
MX367109B (es) * 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EP3268018A4 (en) * 2015-03-12 2018-10-31 The University of British Columbia Bacterial compositions and methods of use thereof
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
KR102066242B1 (ko) 2015-06-09 2020-01-14 리바이오틱스, 인코퍼레이티드 미생물상 복원 치료(mrt) 조성물 및 제조 방법
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US11701394B2 (en) 2017-08-14 2023-07-18 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603876B2 (en) * 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
US20120020941A1 (en) * 2010-07-26 2012-01-26 Suomen Punainen Risti Veripalvelu Use of blood group status iii

Also Published As

Publication number Publication date
US20130195820A1 (en) 2013-08-01
FI20105825A0 (sv) 2010-07-26
US20150104423A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
FI20105825A0 (sv) Användning av blodgrupp status III
SMT201600400B (it) Inalatore
SMT201500291B (it) Nuovi agenti antimalarici
BR112013013026A2 (pt) inalador
DE102010037468A8 (de) Chirurgischer Clip
DK2384731T3 (da) Medicinsk behandlingsvogn
BR112013012217A2 (pt) incubadora
DK2593060T3 (da) Engangsble
FI20105639A0 (sv) Framställning av mikrocellulosa
CU23987B1 (es) Equipo médico
DK2635269T3 (da) Kombinationspræparat
DE112011103919A5 (de) Endoskop
FI20096402A0 (sv) Användning av blodgrupp status II
DK2590565T3 (da) Blodprøvetagning
BR112012027133A2 (pt) inalador
BR112014010432A2 (pt) uso médico
DK2600881T3 (da) Naturlig medicinsk forbindelse
FR2965717B1 (fr) Fauteuil roulant
FR2965715B1 (fr) Fauteuil roulant
FR2956419B1 (fr) Elements de construction calorifuges
FR2959664B1 (fr) Plot podo-tactile
FI20105824A0 (sv) Användning av blodgrupp status IV
PL395785A1 (pl) Zastosowanie medyczne N-etylo-3-amino-4-fenylo-5-okso-2,5-dihydro-1H-pirazolo-1-karbotioamidu
FI20105670A (sv) Användning av ABO typ
FR2955136B1 (fr) Arret de vantail